Sara J. Thompson

Improvement in disability after alemtuzumab treatment of multiple sclerosis is associated with neuroprotective autoimmunity.

K. Selmaj, A. Coles, D. Margolin, 2010, Brain : a journal of neurology.

B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis

A. Coles, Joanne L. Jones, D. Compston, 2009, Journal of Clinical Immunology.

An investigation of auto-reactivity after head injury

D. Menon, D. Chatfield, J. Nortje, 2006, Journal of Neuroimmunology.